The Mosaic Company (MOS) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
Despite some positive aspects like improved production in August and strong performance in Biosciences, there are concerns over extraordinary phosphate costs and unclear responses regarding cost ramp-down. Positive factors like increased potash production and potential Q3 EBITDA growth are balanced by these uncertainties, leading to a neutral sentiment. The lack of specific guidance on certain issues and the market's negative reaction to extraordinary expenses add to the mixed outlook.
Key Financial Performance
Net Income $411 million, compared to a net loss of $162 million in the same quarter of 2024. The improvement was driven by a reversal of foreign exchange effects ($220 million) and a gain in the market value of modern shares ($216 million).
Adjusted EBITDA $566 million, compared to $584 million in the same quarter of 2024. The decline was attributed to larger-than-usual provisions, including $60 million in net unfavorable items such as bad debt expense, inventory adjustments, and asset write-offs.
Phosphate Cash Conversion Cost $126 per tonne in Q2 2025, above the target of $95-$100 per tonne due to low production volumes. However, cash mined rock costs in Florida were the lowest in 10 quarters at $51 per tonne, down from an average of $55 per tonne in 2024.
Potash Cash Production Cost $75 per tonne in Q2 2025, up from the same quarter last year due to less fixed cost absorption and lower yield, but down from $78 in Q1 2025.
Mosaic Fertilizantes EBITDA $150 million in Q2 2025, driven by $106 million in cost reductions and higher realized prices, despite an $18 million bad debt expense net of recoveries.
SG&A Cost Reductions Achieved $150 million in cost reductions, primarily from Mosaic Fertilizantes and SG&A. The target has been extended to $250 million by the end of 2026 through further automation, supply chain optimization, and fixed cost absorption.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Mosaic Biosciences revenue growth: First half revenues for Biosciences more than doubled compared with a year ago. Expected to contribute positively to adjusted EBITDA beginning in Q4.
New Palmeirante facility: Inaugurated last month, adds 1 million tonnes of distribution capacity in northern Brazil.
Phosphate market dynamics: Global phosphate market remains tight with robust farmer demand and limited supply. Indian importers are addressing two years of pent-up demand with government support.
Potash market dynamics: Market shifted from balanced to tight due to reduced supply from maintenance activities globally. Prices are expected to hold steady with strong demand in Southeast Asia and resilient Brazilian demand.
U.S. phosphate production improvements: Maintenance work completed at key facilities, targeting 8 million tonnes per year. Annual guidance adjusted to 6.9-7.2 million tonnes due to downtime.
Cost reduction in Brazil: Achieved $106 million of $150 million cost reduction target in Mosaic Fertilizantes segment, with further reductions expected.
Potash production increase: Annual production guidance raised to 9.3-9.5 million tonnes to meet strong global demand.
Capital allocation strategy: Focus on reclaiming capital for better returns, including projects like the hydrofloat project and Palmeirante facility. Stronger free cash flow expected in H2 2025 to pay down debt and return capital to shareholders.
Cost reduction extension: Extended cost reduction target from $150 million to $250 million by 2026 through automation, supply chain optimization, and operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Phosphate Production Delays: The extensive maintenance downtime in June and July delayed production, impacting the company's ability to meet its annual phosphate production targets. This could affect financial performance and operational efficiency.
Bad Debt Expense: A $30 million bad debt expense was recorded in Mosaic Fertilizantes, though 90% is backed by insurance. This reflects credit issues in Brazil, which could pose ongoing financial risks.
Turnaround and Idle Expenses: Elevated turnaround and idle expenses, particularly in phosphates, have increased costs and reduced production volumes. While these are expected to normalize, they have impacted short-term financial performance.
Credit Issues in Brazil: Persistent credit issues in Brazil could limit sales volumes and impact financial performance, despite strong fertilizer demand.
Global Supply Constraints: Tight global supply of phosphate and potash fertilizers, exacerbated by maintenance activities and export restrictions in key regions like China, could limit the company's ability to meet demand.
Demand Deferral in Americas: Fertilizer affordability issues in the Americas may lead to demand deferral, impacting short-term sales and revenue.
Environmental and Legal Reserves: The company recorded $8 million in environmental reserves and $4 million in legal reserves, indicating potential future liabilities.
Market Volatility: Pressure on agricultural commodity markets due to trade and macroeconomic uncertainties could impact demand for fertilizers.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Phosphate Market Outlook: The global phosphate market is expected to remain tight well into 2026, with robust farmer demand and limited additional capacity coming online. Mosaic anticipates reaching its target run rate of 8 million tonnes per year for U.S. phosphate production, with annual guidance for phosphate production set at 6.9 to 7.2 million tonnes for 2025.
Potash Market Outlook: The potash market has shifted from balanced to tight, with strong global demand and reduced supply due to maintenance activities. Mosaic has increased its annual potash production guidance to 9.3 to 9.5 million tonnes for 2025. Prices are expected to hold steady, supported by strong demand in Southeast Asia and resilient Brazilian demand.
Brazil Operations and Fertilizer Demand: Mosaic expects strong fertilizer demand in Brazil despite credit issues, with EBITDA from the Mosaic Fertilizantes segment anticipated to increase in the second half of 2025. The new Palmeirante facility adds 1 million tonnes of distribution capacity, reinforcing Mosaic's market presence in the region.
Mosaic Biosciences Growth: Mosaic Biosciences is expected to contribute positively to adjusted EBITDA starting in Q4 2025, with first-half revenues more than doubling compared to the previous year.
Capital Allocation and Cost Reductions: Mosaic plans to achieve an additional $100 million in cost reductions by the end of 2026, extending its total cost reduction target to $250 million. The company also expects stronger free cash flow in the second half of 2025, enabling debt reduction and shareholder returns.
Q3 2025 EBITDA Expectations: EBITDA in all segments is expected to be significantly higher in Q3 2025 compared to Q2, driven by increased production volumes, reduced turnaround expenses, and favorable market conditions.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Program: The company expects stronger free cash flow in the second half of the year, which would allow them to return capital to shareholders.
Share Buyback Program: No specific mention of a share buyback program was made in the transcript.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why does the market seem to be reacting negatively to the company's performance despite no major changes since Investor Day?
A:The market's reaction may be due to extraordinary expenses and production volume changes in phosphates. The company faced delays in upgrading its phos acid waste disposal systems, which impacted production. Additionally, $50 million of expenses in phosphates were deemed non-normal and extraordinary. However, other areas like potash costs and Biosciences are performing well, and Analyst Day targets are on track.
Q:What was the company's run rate in July, and how is it trending in August and September?
A:The July run rate was below expectations due to delays in completing the third pumping system at New Wales. However, early August numbers are encouraging, with improvements seen in Louisiana and Bartow operating at full capacity. The company is confident in achieving its guidance of 1.8 to 2 million tonnes for the balance of the year.
Q:How do the $50 million of extraordinary costs in Q2 ramp down in subsequent quarters?
A:Management did not provide a specific quarter-by-quarter breakdown of the ramp-down but mentioned that annualized turnaround costs for phosphates are typically $100-110 million. The lumpiness of these costs depends on unit operation schedules, and the company expects normalized ongoing costs to align with historical averages.
Q:What measures has the company taken to prepare for the hurricane season in Florida?
A:The company has hardened assets by elevating motor control centers, improving wind resistance in buildings, and ensuring compliance with regulatory requirements for gypsum stacks and clay settling areas. They also have contingency plans, including power and pumping backups, to manage potential storm impacts.
Q:Are there any major maintenance items remaining that could impact production going forward?
A:No major maintenance items remain. The company has completed all planned maintenance for asset health and reliability. The recent bottleneck issues at New Wales due to gypsum handling systems have been resolved, and no similar issues are expected at other facilities.
Q:How have tariffs impacted the cost of phosphate imports into the U.S.?
A:Imports of phosphate generally have a 10% tariff, with no current tariffs on Russian imports. The company’s raw material costs are minimally impacted by tariffs, as most sulfur and ammonia are sourced domestically or from tariff-exempt regions.
Q:What does the asset health target of 85-95% mean, and how does it account for planned and unplanned outages?
A:The asset health target reflects the timing of turnarounds, with health decreasing over time until the next turnaround. It accounts for normal unplanned downtime but excludes extraordinary unplanned outages. The company expects minimal unplanned outages going forward due to improved asset health.
Q:What is the earnings potential of the Fertilizantes business in a mid-cycle scenario?
A:The Fertilizantes business has the potential to generate $300-500 million from distribution and an additional $300-350 million from self-produced tonnes, with coproducts contributing around $40 million per quarter. The long-term EBITDA potential is approximately $1 billion, supported by growth in northern Brazil and new product launches in Biosciences.
Q:Why did phosphate specialties pricing appear lower in Q2?
A:Management did not directly address this question during the call, suggesting it may require further analysis offline due to the complexity of factors like feed products and other inputs.
Q:What is happening on the ground in Brazil, and how is the company addressing credit challenges?
A:The summer soybean season is slow due to high input costs, low crop prices, and credit challenges. However, the second corn crop season is progressing well, with farmers purchasing fertilizers in advance. The company is focusing on customers with better credit profiles and expanding in northern Brazil, where growth is expected.
Q:How much better can Q3 EBITDA be compared to Q2?
A:Management did not provide specific EBITDA guidance but highlighted several tailwinds, including higher phosphate and potash prices, increased volumes, reduced turnaround costs, and improved conversion costs. These factors are expected to drive significant sequential growth in Q3 EBITDA.
Q:Review of Unclear Management Responses
A:Management avoided directly answering the question about the specific ramp-down of the $50 million extraordinary costs in Q2, instead providing general annualized cost estimates. Additionally, the question about phosphate specialties pricing in Q2 was not directly addressed, with management suggesting further analysis offline.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Americas
Capital Markets
China export
India
LLC
Luciano
Markets Research
President Commercial
Research Division
Southeast Asia
advantage market
ag market
allocation progress
asset production
demand dynamic
demand fertilizer
demand supply
effect
environment
facility
fall
geography
government support
import
input
maintenance
market access
market year
oil price
palm oil
phosphate potash
potash production
price reset
producer
production tonne
shipment record
shipment supply
station
supply side
term supply
MOS Transcript
The Mosaic Company (MOS) Q1 2026 Earnings Call Transcript
Unknown5-11
The earnings call summary reveals a decline in key financial metrics, including revenue, gross margin, net income, and EPS, all down significantly year-over-year. The absence of discussions on operational updates, strategic initiatives, or shareholder returns suggests a lack of positive catalysts. The Q&A section provided no additional clarity or positive sentiment. The forward-looking statements highlight significant risks, and no guidance or optimistic outlook was offered to counterbalance the negative financial results. These factors collectively suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
The Mosaic Company (MOS) Q4 2025 Earnings Call Transcript
Unknown2-25
The earnings call summary presents a mixed outlook. While there are positive aspects like potential working capital release from excess inventory and optimistic production targets, there are also challenges such as farmer affordability issues and high sulfur prices impacting margins. The Q&A indicates management's optimism but also highlights uncertainties, particularly in pricing and cost management. Overall, the sentiment is balanced with both positive and negative factors, leading to a neutral stock price prediction.
The Mosaic Company (MOS) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call shows strong demand and stable prices in phosphate and potash markets, with positive EBITDA expectations. However, concerns over workforce turnover, institutional knowledge gaps, and potential demand deferral in Q4 phosphate sales create uncertainties. Despite operational improvements and cost reduction plans, the unclear management responses in the Q&A section add to the mixed sentiment. The neutral rating reflects these balancing positive and negative factors.
The Mosaic Company (MOS) Q2 2025 Earnings Call Transcript
Unknown8-6
Despite some positive aspects like improved production in August and strong performance in Biosciences, there are concerns over extraordinary phosphate costs and unclear responses regarding cost ramp-down. Positive factors like increased potash production and potential Q3 EBITDA growth are balanced by these uncertainties, leading to a neutral sentiment. The lack of specific guidance on certain issues and the market's negative reaction to extraordinary expenses add to the mixed outlook.
MOS Slides
MOS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
